Clinical Trials Directory

Trials / Conditions / High-risk Non-muscle Invasive Bladder Cancer

High-risk Non-muscle Invasive Bladder Cancer

7 registered clinical trials studyying High-risk Non-muscle Invasive Bladder Cancer — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Re
NCT07468851
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 / Phase 2
Not Yet RecruitingA Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle
NCT07483970
Jecho Biopharmaceuticals Co., Ltd.Phase 1
Not Yet RecruitingA Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Baci
NCT07268339
The Christie NHS Foundation TrustPhase 3
RecruitingPhase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
NCT06567743
CG Oncology, Inc.Phase 2
RecruitingTo Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in P
NCT06378242
RemeGen Co., Ltd.Phase 1 / Phase 2
Active Not RecruitingEfficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk
NCT03711032
Merck Sharp & Dohme LLCPhase 3
CompletedImmunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RU
NCT03191578
Archivel Farma S.L.Phase 1